Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.32 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15305012 | 0.96 | GCGR (0.38) | GCGRKMT2AMITFALDH1A1TP53 | |
| SCHEMBL12851903 | 0.84 | GCGR (0.34) | GCGRCCNB2CDK1CCNB1GSK3A | |
| SCHEMBL12851691 | 0.82 | ALDH1A1 (0.41) | GCGRKMT2AALDH1A1TP53CCNB2 | |
| SCHEMBL12851834 | 0.82 | ALDH1A1 (0.41) | GCGRKMT2AALDH1A1TP53CCNB2 | |
| SCHEMBL10082086 | 0.74 | GCGR (0.40) | GCGRKMT2AMITFALDH1A1TP53 | |
| SCHEMBL186253 | 0.72 | GCGR (0.47) | GCGRKMT2AMITFALDH1A1TP53 | |
| SCHEMBL10082012 | 0.70 | GCGR (0.40) | GCGRKMT2AMITFALDH1A1TP53 | |
| SCHEMBL15305019 | 0.70 | NR1H4 (0.33) | NPC1RAB9A | |
| SCHEMBL15946100 | 0.69 | GCGR (0.36) | GCGRKMT2AMITFALDH1A1TP53 | |
| SCHEMBL186808 | 0.68 | GCGR (0.43) | GCGRKMT2AMITFALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8778510-B2 | Pyrromethene-boron complex compounds and organic electroluminescent elements using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-15 | — | — | US | disclosed |
| US-8778510-B2 | Pyrromethene-boron complex compounds and organic electroluminescent elements using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-2402351-B1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTRO- LUMINESCENT ELEMENTS USING SAME | IDEMITSU KOSAN CO (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20120037890-A1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME | MITSUI CHEMICALS, INC. | 2012-02-16 | — | — | US | disclosed |
| US-20120037890-A1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME | MITSUI CHEMICALS, INC. | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120037890-A1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME | LEF1, ZRANB2, AFF1 | GCGR 2138/4885KMT2A 1733/4885MITF 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.